Bioreactor Volume Fundamentals
Bioreactor sizing is the process of selecting a vessel volume that meets your production throughput target while fitting within facility, utility, and budget constraints. Get the sizing wrong, and you either overspend on an oversized vessel or face chronic capacity shortfalls that delay product supply.
The core calculation is straightforward: how much product do you need per year, divided by how much each batch produces. But the details — working volume ratios, turnaround time, downstream recovery losses, and seed train requirements — turn a one-line equation into a multi-variable engineering decision.
This guide walks through every step of bioreactor sizing calculation, from converting annual demand into working volume, to choosing vessel geometry, to planning the seed train that feeds your production reactor. All equations include worked examples with real numbers from monoclonal antibody (mAb) and microbial fermentation processes.
Working Volume vs Total Vessel Volume
Working volume is the actual liquid volume in the bioreactor during operation, typically 70–80% of the total vessel volume for stirred-tank reactors. The remaining 20–30% is headspace required for foam, gas disengagement, and liquid splashing from agitation.
The relationship between total vessel volume (VT) and working volume (VW) is:
VW = VT × fw
Where fw is the working volume fraction. Typical values depend on the reactor type and application:
| Bioreactor Type | Working Volume Fraction (fw) | Typical Headspace | Notes |
|---|---|---|---|
| Stirred-tank (stainless steel) | 0.70–0.80 | 20–30% | Standard for microbial & mammalian |
| Stirred-tank (single-use) | 0.70–0.75 | 25–30% | Bag geometry limits fill level |
| Wave-mixed / rocking | 0.40–0.50 | 50–60% | Requires space for wave motion |
| Airlift / bubble column | 0.75–0.85 | 15–25% | No impeller, less splashing |
| Shake flask | 0.10–0.30 | 70–90% | Low fill for oxygen transfer |
For fed-batch processes, account for the feed volume that will be added during the run. If you start at 60% of vessel volume and add 15% over the batch, your effective initial working volume fraction drops to 0.60 but the final volume reaches 0.75 of VT.
Sizing from Annual Production Demand
The most practical bioreactor sizing calculation starts with your annual product requirement and works backwards to the vessel volume needed per batch. This demand-driven approach ensures your facility can actually deliver the kilograms of product your commercial or clinical programme requires.
The core bioreactor sizing equation is:
VW = D / (Cp × Yds × N)
Where:
- VW = working volume per batch (L)
- D = annual product demand (g/year)
- Cp = product titer in harvest (g/L)
- Yds = downstream recovery yield (fraction, typically 0.60–0.80)
- N = number of batches per year
The number of batches per year depends on batch duration and turnaround time:
N = Tavailable / (tbatch + tturnaround)
Where Tavailable is the annual operating time (typically 330–350 days to allow for planned maintenance), tbatch is the culture duration, and tturnaround covers CIP, SIP, media prep, and inoculation.
Worked Example — mAb Production Bioreactor Sizing
Given:
- Annual demand: 100 kg purified mAb
- Product titer: 5 g/L (fed-batch CHO cell culture)
- Downstream recovery yield: 70% (Protein A + polishing)
- Batch duration: 14 days
- Turnaround time: 3 days (CIP, SIP, media charge)
- Available operating days: 340 days/year
Step 1 — Batches per year:
N = 340 / (14 + 3) = 20 batches/year
Step 2 — Working volume per batch:
VW = 100,000 g / (5 g/L × 0.70 × 20) = 1,429 L
Step 3 — Total vessel volume:
VT = 1,429 / 0.75 = 1,905 L → select a 2,000 L vessel
Result: A single 2,000 L bioreactor meets the 100 kg/year mAb target.
As the chart shows, doubling the titer from 2.5 g/L to 5 g/L halves the bioreactor volume requirement. This is why titer improvement is one of the highest-impact process development activities — it directly reduces capital cost by allowing smaller vessels.
Fermentation Economics Calculator
Model COGS per gram across different vessel sizes, titers, and batch numbers to find the most economical bioreactor configuration.
Vessel Geometry and Aspect Ratios
The height-to-diameter ratio (H:D, also called aspect ratio) determines the vessel shape and directly affects mixing, oxygen transfer, and CO2 stripping performance. Standard stirred-tank bioreactors use an H:D ratio of 2:1, though this varies by application.
| Application | H:D Ratio | Vessel Volume Range | Rationale |
|---|---|---|---|
| Mammalian cell culture | 1.5:1 – 2:1 | 50 – 25,000 L | Low shear, uniform mixing |
| Microbial fermentation | 2.5:1 – 3:1 | 10 – 500,000 L | Higher OTR from hydrostatic pressure |
| Yeast / baker’s yeast | 4:1 – 6:1 | 50,000 – 300,000 L | Maximum oxygen transfer |
| Lab-scale stirred tank | 1:1 – 2:1 | 0.25 – 10 L | Compact bench footprint |
| Single-use (bag) | 1:1 – 1.5:1 | 50 – 2,000 L | Bag geometry constraints |
Given the H:D ratio and volume, you can calculate the vessel diameter. For a cylindrical vessel:
D = (4 × VT / (π × H/D))^(1/3)
Worked Example — Vessel Dimensions
Given: 2,000 L total vessel volume, H:D = 2:1
D = (4 × 2.0 m³ / (π × 2))^(1/3) = (1.273)^(1/3) = 1.084 m ≈ 1.08 m
H = 2 × 1.08 = 2.16 m
Result: The vessel is approximately 1.08 m diameter × 2.16 m tall (excluding head and legs). Add ~30% to height for dished heads, nozzles, and support structure for the installed height of approximately 2.8 m.
Impeller diameter (Di) is typically 0.33–0.50 of the tank diameter. For a 1.08 m tank, the impeller would be 0.36–0.54 m. Multi-impeller configurations are standard when H:D exceeds 2:1 — use one impeller per tank-diameter height increment.
Seed Train Sizing
Each seed train stage should be sized at 5–20% of the next vessel’s working volume, with a 10% split ratio (1:10) being the most common. This ensures cells are inoculated at a sufficient density to establish exponential growth quickly without an extended lag phase.
For mammalian cell culture, the typical inoculation density is 0.3–0.5 × 106 cells/mL, expanded from a seed density of 3–5 × 106 cells/mL in the preceding vessel. Microbial seed trains often use higher inoculum fractions (5–10% v/v) because faster growth rates tolerate lower starting densities.
The total seed train duration adds significantly to the overall campaign timeline. For the 2,000 L example above, 13 days of seed expansion precede each 14-day production batch. Perfusion-based intensified seed trains (using N−1 perfusion) can reduce the number of expansion stages by achieving higher cell densities in a smaller vessel, cutting seed train time by 3–6 days.
Seed Train Planner
Plan your complete seed train expansion from vial thaw to production bioreactor with automatic volume and timing calculations.
One Large Reactor vs Multiple Smaller Units
Choosing between one large bioreactor and multiple smaller units involves trade-offs between capital cost, operational flexibility, and risk tolerance. The break-even point depends on your annual demand, product value, and manufacturing strategy.
| Factor | Single Large (e.g., 1 × 10,000 L) | Multiple Small (e.g., 4 × 2,500 L) |
|---|---|---|
| Capital cost | Lower per litre | Higher per litre (more vessels, piping, controls) |
| Operating cost | Lower labour, fewer CIP/SIP cycles | Higher labour, more changeovers |
| Batch failure risk | High — entire campaign output lost | Low — one failed batch is 25% of capacity |
| Scheduling flexibility | Sequential batches only | Stagger batches for continuous harvest |
| Multi-product capability | One product at a time | Run different products in parallel |
| Facility footprint | Smaller cleanroom | Larger or segregated suites |
| Scale-up risk | Longer development path | Easier to validate at smaller scale |
As a general guideline: for annual demands under 200 kg of mAb (at current titers of 3–5 g/L), multiple 1,000–2,000 L single-use bioreactors are often more cost-effective than one large stainless-steel vessel. Above 500 kg/year, 10,000–20,000 L stainless-steel reactors become more economical on a per-kilogram basis. The crossover zone (200–500 kg/year) depends heavily on facility layout, product portfolio, and timeline constraints.
Bioreactor Scale Categories
Bioreactors span five orders of magnitude in volume, from bench-top screening to commercial manufacturing. Each scale has distinct purposes, equipment types, and design constraints for bioreactor sizing.
| Scale | Working Volume | Primary Use | Typical Reactor Types | Number of Impellers |
|---|---|---|---|---|
| Screening | 1–50 mL | Clone selection, media screening | Microbioreactors, shake plates | N/A (orbital shaking) |
| Bench | 0.25–10 L | Process development, DOE studies | Glass STR, mini-bioreactors | 1–2 |
| Pilot | 10–500 L | Scale-up validation, tox lot production | Stainless STR, single-use bags | 1–3 |
| Clinical / small-scale production | 500–2,000 L | Phase III supply, niche products | Single-use STR, stainless STR | 2–3 |
| Commercial manufacturing | 2,000–25,000 L | Full-scale drug substance production | Stainless STR, large single-use | 2–4 |
| Large-scale microbial | 50,000–500,000 L | Antibiotics, enzymes, biofuels | Stainless STR, airlift | 3–6 |
When selecting a production bioreactor size, consider the entire lifecycle: clinical-phase vessels should be large enough to supply Phase III trials (often 500–2,000 L), and the design should allow clear scale-up to commercial volumes. A 10× scale-up between development and production is generally considered manageable; greater than 50× introduces significant process risk.
For further guidance on maintaining constant scale-up criteria (P/V, tip speed, VVM) as you move between scales, see our Scale-Up Criteria Comparison guide. For practical aeration considerations during sizing, read the Bioreactor Aeration Scale-Up guide.
Scale-Up Calculator
Calculate impeller speed, tip speed, P/V, and Reynolds number when scaling between bioreactor sizes. Maintains geometric similarity.
Frequently Asked Questions
How do you calculate the bioreactor volume needed for a given annual demand?
Divide your annual product demand (kg/year) by the product titer (g/L), downstream recovery yield (typically 60–80%), and number of batches per year. The result is the working volume per batch. For example, producing 100 kg/year of a mAb at 5 g/L titer with 70% recovery and 20 batches/year requires a working volume of approximately 1,429 L per batch, meaning a 2,000 L vessel.
What is the difference between total vessel volume and working volume?
Total vessel volume is the full internal capacity of the bioreactor tank, while working volume is the actual liquid volume used during operation. Working volume is typically 70–80% of total vessel volume for stirred-tank reactors. The remaining 20–30% is headspace needed for foam, gas disengagement, and splashing from agitation.
What bioreactor sizes are used in industrial mAb production?
Industrial monoclonal antibody production typically uses 5,000–25,000 L bioreactors in fed-batch mode, with batch durations of 10–17 days. At current titers of 3–5 g/L, a single 15,000 L bioreactor running 20 batches per year can produce 600–1,500 kg of crude mAb before downstream losses.
How do you size the seed train for a production bioreactor?
Size each seed train stage at 5–20% of the next vessel volume (10% is most common, giving a 1:10 split ratio). Work backwards from the production bioreactor: for a 2,000 L production vessel, a typical seed train is 0.2 L flask → 2 L → 20 L → 200 L → 2,000 L.
Should I use one large bioreactor or multiple smaller ones?
For annual demands under 200 kg of mAb, multiple 1,000–2,000 L single-use bioreactors are often more cost-effective. Above 500 kg/year, 10,000–20,000 L stainless-steel reactors become more economical per kilogram. The 200–500 kg/year range depends on facility constraints and product portfolio.
What is the standard height-to-diameter ratio for a bioreactor?
Standard stirred-tank bioreactors use H:D of 2:1 for mammalian cell culture and 2.5:1 to 3:1 for microbial fermentation. Taller vessels increase hydrostatic pressure and oxygen transfer but create CO2 gradients that can harm shear-sensitive cells. Single-use bioreactors typically have lower ratios of 1:1 to 1.5:1 due to bag geometry constraints.
Related Bioprocess Tools
- Scale-Up Calculator — Calculate impeller speed, tip speed, P/V, and Reynolds number when scaling between vessel sizes
- Fermentation Economics Calculator — Model COGS per gram across different bioreactor volumes and operating modes
- Seed Train Planner — Plan complete seed train expansion from vial thaw to production vessel
References
- Shuler ML, Kargi F. Bioprocess Engineering: Basic Concepts. 2nd ed. Prentice Hall; 2002. Chapters 6–9.
- Xing Z, Kenty BM, Li ZJ, Lee SS. Scale-up analysis for a CHO cell culture process in large-scale bioreactors. Biotechnol Bioeng. 2009;103(4):733-746. doi:10.1002/bit.22287
- Shukla AA, Thoemmes J. Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol. 2010;28(5):253-261. doi:10.1016/j.tibtech.2010.02.001
- Farid SS. Process economics of industrial monoclonal antibody manufacture. J Chromatogr B. 2007;848(1):8-18. doi:10.1016/j.jchromb.2006.07.037
- Kelley B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs. 2009;1(5):443-452. doi:10.4161/mabs.1.5.9448